Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Issa GC, Cuglievan B, El Hajjar G, Jen WY, et al. The All-Oral Combination of Revumenib, Decitabine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia (SAVE). J Clin Oncol 2026 Jun 11:101200JCO2601159. doi: 10.1200/JCO-26-01159.
PMID: 42272166


Privacy Policy